Suspensory trigemino-sympathetic novocaine blockade
M. P. Zhakov
Kazan medical journal ›› 1960, Vol. 41 ›› Issue (5) : 66 -66.
Suspensory trigemino-sympathetic novocaine blockade
The suspensory trigemino-sympathetic novocaine blockade was developed by the author and put into practice in 1953. Its therapeutic value is based on the effect of: 0.25% novocaine solution on the maxillary and mandibular nerves (the second and third branches of the trigeminal nerve) with their branches and other nerve formations located in the sublingual and wing palatine fossa.
Eco-Vector
/
| 〈 |
|
〉 |
PDF
